AREAS OF CONCENTRATION
- Litigation
- Appellate
- Federal District Court
- Hatch-Waxman
- Client Counseling
- Developing Pre-Litigation Strategy
- Opinion of Counsel: Patentability, Freedom-to-Operate, Infringement, Invalidity
- Due Diligence
- Licensing and Transactions
- Patent Prosecution
- Biotechnology
- Chemical
- Pharmaceutical
- Medical Devices
EDUCATION
- B.S. Pharmacy from Seoul National University - 1989
- M.S. International Law from Sung Kyun Kwan University - 1998
- L.L.M. in Intellectual Property from George Washington University - 1999
BAR ADMISSIONS
- District of Columbia Bar
- New York State Bar
PUBLICATIONS AND PRESENTATIONS
- "Patent Law Perspective on the Report of the Federal Trade Commission on Balancing Competition and Patent Law and Policy" written by E. Anthony Figg, C. Nichole Gifford and, and presented to the ABA Section of Antitrust Law, May 2004
- "How the 2003 Hatch-Waxman Reform Has Changed NDA/Generic Practice in the U.S,” presented in the Symposium sponsored by Darae Law & Patent Firm,November 9, 2005
- "The Norvasc CAFC Decision and Thereafter,” presented in the Symposium sponsored by Daily Pharm, June 21, 2007, Korea
- "Obviousness after KSR," presented in the Symposium sponsored by Daily Pharm, June 21, 2007, Seoul, Korea
- “U.S. Generic Market,” taught in the program entitled “Strategies for Exporting Pharmaceutical Products to the U.S. Market,” sponsored by Korea Health Industry Development Institute and Pharmaceutical Industries, October 12, 2007
|
JOO MEE KIM Member
Ms. Kim’s practice focuses on litigating patent cases and counseling clients for obtaining, licensing and enforcing patents in various technology areas including pharmaceutical, biotechnology, chemical, electronics and mechanical areas.
Ms. Kim’s practice also includes counseling clients for maximizing licensing revenue from patented and patentable technologies.She also counsels various clients in pharmaceutical, biotechnology, chemical, biomedical and electronic areas for strategic exploitation of their patents and for development of effective defenses against infringement allegations. Ms. Kim has represented clients in a broad range of due diligence associated with merger and acquisition and has provided written opinions to evaluate freedom-to-operate, invalidity and/or infringement issues in the technical field of pharmaceuticals, genetic engineering, molecular biology, monoclonal antibodies, cancer treatments, and protein production in plants.
Before practicing in the U.S., as a senior Korean patent attorney at a general law firm in Korea for more than seven years, Ms. Kim worked extensively on patent infringement litigation cases brought by major U.S., Japan and European pharmaceutical, chemical and biotech companies including Astra Zeneca, Nissan Chemical and Merck. Ms. Kim also prosecuted various patent applications for U.S., Japan and European companies.
Email Attorney
Print Bio
Download Full Bio
Download V-Card
|